SCHEMBL21396971

SCHEMBL21396971

N#Cc1c(-c2cc(-n3c4ccccc4c4ccccc43)ccn2)cc(-n2c3ccccc3c3ccccc32)cc1-c1cc(-n2c3ccccc3c3ccccc32)ccn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
ATM Q13315 1/20 0.38
GRM5 P41594 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.35
RECQL P46063 1/20 0.35
CYP11B2 P19099 1/20 0.33
ALDH1A1 P00352 5/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
MAPT P10636 2/20 0.33
TSHR P16473 2/20 0.33
GLA P06280 2/20 0.33
GAA P10253 2/20 0.33
HPGD P15428 2/20 0.33
POLB P06746 1/20 0.33
PTGER4 P35408 1/20 0.33
EGFR P00533 1/20 0.33
SRC P12931 1/20 0.33
SQOR Q9Y6N5 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21396696 0.86 GRM5 (0.35) KDM4EL3MBTL1ATMGRM5SMN1; SMN2
SCHEMBL21396751 0.85 MAPK1 (0.38) KDM4EL3MBTL1ATMGRM5SMN1; SMN2
SCHEMBL21397134 0.82 GRIA1 (0.35) KDM4EL3MBTL1ATMGRM5SMN1; SMN2
SCHEMBL21396970 0.82 GRM5 (0.46) KDM4EL3MBTL1ATMGRM5PTGER4
SCHEMBL21396749 0.81 KDM4E (0.38) KDM4EL3MBTL1ATMSMN1; SMN2RECQL
SCHEMBL15469063 0.81 KDM4E (0.52) KDM4EL3MBTL1ATMALDH1A1POLB
SCHEMBL21396954 0.81 GRM5 (0.35) KDM4EL3MBTL1ATMGRM5SMN1; SMN2
SCHEMBL21397127 0.80 GRM5 (0.42) KDM4EL3MBTL1ATMGRM5ALDH1A1
SCHEMBL21396685 0.79 GRM5 (0.48) KDM4EL3MBTL1ATMGRM5ALDH1A1
SCHEMBL21396969 0.79 KDM4E (0.36) KDM4EL3MBTL1ATMGRM5SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190296247-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2019-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190296247-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SLC25A21, SLCO4C1, SLC18A1 KDM4E 955/4885L3MBTL1 1378/4885ATM 4028/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.